NCT01935934 2025-10-01Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerNational Cancer Institute (NCI)Phase 2 Completed102 enrolled 14 charts
NCT02728258 2022-02-15Copanlisib in Treating Patients With Persistent or Recurrent Endometrial CancerNRG OncologyPhase 2 Completed11 enrolled 12 charts